Drug Shortage Report for M-CLOPIDOGREL
| Report ID | 175303 |
| Drug Identification Number | 02502283 |
| Brand name | M-CLOPIDOGREL |
| Common or Proper name | Clopidogrel |
| Company Name | MANTRA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CLOPIDOGREL |
| Strength(s) | 75MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 500 |
| ATC code | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2022-11-07 |
| Estimated end date | 2023-02-28 |
| Actual end date | 2023-03-02 |
| Shortage status | Resolved |
| Updated date | 2023-03-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2023-03-06 | French | Compare |
| v7 | 2023-03-06 | English | Compare |
| v6 | 2023-02-20 | French | Compare |
| v5 | 2023-02-20 | English | Compare |
| v4 | 2023-01-20 | French | Compare |
| v3 | 2023-01-20 | English | Compare |
| v2 | 2022-11-18 | French | Compare |
| v1 | 2022-11-18 | English | Compare |
Showing 1 to 8 of 8